| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Leonard L. Mazur | Chief Executive Officer, Director | $9,790,000 | 19 Sep 2025 | ||
| Myron Z. Holubiak | Secretary, Director | $4,268,000 | 19 Sep 2025 | ||
| Myron Czuczman | Chief Medical Officer | $3,924,250 | 19 Sep 2025 | ||
| Jaime Bartushak | Chief Financial Officer | $3,924,250 | 19 Sep 2025 | ||
| Joel David Mayersohn | Director | $911,185 | 19 Sep 2025 | ||
| Carol Webb | Director | $676,500 | 19 Sep 2025 | ||
| Dennis M. Mcgrath | Director | $676,500 | 19 Sep 2025 | ||
| Eugene Myron Holuka | Director | $676,500 | 19 Sep 2025 | ||
| Suren G. Dutia | Director | $676,500 | 19 Sep 2025 | ||
| Robert Joseph Smith | Director | $624,250 | 19 Sep 2025 | ||
| Citius Pharmaceuticals, Inc. | 10%+ Owner | 12 Aug 2024 | |||
| Dahe Zhang | Chief Financial Officer, Director, 10%+ Owner | 13 Oct 2022 | |||
| Brian Shawn Hartzband | Director | 13 Oct 2022 | |||
| Xiaofeng Yuan | Chief Executive Officer, Director, 10%+ Owner | 13 Oct 2022 | |||
| Cathy Jiang | Director | 13 Oct 2022 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Carol Webb | CTOR | Common Stock | Award | 300,000 | 300,000 | 19 Sep 2025 | Direct | |||
| Myron Z. Holubiak | CTOR | Common Stock | Award | 850,000 | 850,000 | 19 Sep 2025 | Direct | |||
| Myron Czuczman | CTOR | Common Stock | Award | 825,000 | 825,000 | 19 Sep 2025 | Direct | |||
| Jaime Bartushak | CTOR | Common Stock | Award | 825,000 | 825,000 | 19 Sep 2025 | Direct | |||
| Leonard L. Mazur | CTOR | Common Stock | Award | 1,700,000 | 1,700,000 | 19 Sep 2025 | Direct | |||
| Robert Joseph Smith | CTOR | Common Stock | Award | 300,000 | 300,000 | 19 Sep 2025 | Direct | |||
| Dennis M. Mcgrath | CTOR | Common Stock | Award | 300,000 | 300,000 | 19 Sep 2025 | Direct | |||
| Joel David Mayersohn | CTOR | Common Stock | Award | 1413.2% | 300,000 | 321,228 | 19 Sep 2025 | Direct | ||
| Suren G. Dutia | CTOR | Common Stock | Award | 300,000 | 300,000 | 19 Sep 2025 | Direct | |||
| Eugene Myron Holuka | CTOR | Common Stock | Award | 300,000 | 300,000 | 19 Sep 2025 | Direct | |||
| Eugene Myron Holuka | CTOR | Common Stock | Award | 300,000 | 300,000 | 19 Sep 2025 | Direct | |||
| Joel David Mayersohn | CTOR | Common Stock | Award | 1413.2% | 300,000 | 321,228 | 19 Sep 2025 | Direct | ||
| Carol Webb | CTOR | Common Stock | Award | 300,000 | 300,000 | 19 Sep 2025 | Direct | |||
| Dennis M. Mcgrath | CTOR | Common Stock | Award | 300,000 | 300,000 | 19 Sep 2025 | Direct | |||
| Jaime Bartushak | CTOR | Common Stock | Award | 825,000 | 825,000 | 19 Sep 2025 | Direct | |||
| Myron Z. Holubiak | CTOR | Common Stock | Award | 850,000 | 850,000 | 19 Sep 2025 | Direct | |||
| Robert Joseph Smith | CTOR | Common Stock | Award | 300,000 | 300,000 | 19 Sep 2025 | Direct | |||
| Suren G. Dutia | CTOR | Common Stock | Award | 300,000 | 300,000 | 19 Sep 2025 | Direct | |||
| Leonard L. Mazur | CTOR | Common Stock | Award | 1,700,000 | 1,700,000 | 19 Sep 2025 | Direct | |||
| Myron Czuczman | CTOR | Common Stock | Award | 825,000 | 825,000 | 19 Sep 2025 | Direct | |||
| Joel David Mayersohn | CTOR | Common Stock | Other | 21,228 | 21,228 | 28 Jul 2025 | Direct |